col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


22 Ergebisse       Seite 1

 [1] 
Springer (Biomed Central Ltd.): Pneumonia
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2025―Nov―25 Immunosuppressed patients with COVID-19 pneumonia in ICU: clinical characteristics and factors influencing outcomes Flavia Galli, Edoardo Forin, Ana Motos, Francisco José Molina Saldarriaga, Albert Gabarrus, Joan Canseco, et al. (+245)
2 [GO] 2025―Jul―04 Organizing pneumonia in hospitalized COVID-19 patients: risk factors and long-term outcomes Sandra Cuerpo, Fernanda Hernandez-Gonzalez, Mariana Benegas, Nuria Albacar, Alejandra Lopez-Giraldo, Inés Cobo, et al. (+24)
3 [GO] 2025―Jun―04 Are presentations of thoracic CT performed on admission to the ICU associated with mortality at day-90 in COVID-19 related ARDS? Alexia Le Corre, Adel Maamar, Mathieu Lederlin, Nicolas Terzi, Jean-Marc Tadié, Arnaud Gacouin
4 [GO] 2025―Mai―24 Clinical effectiveness of oral antiviral treatment for non-hospitalized high-risk patients with COVID-19 during Omicron JN.1 subvariant wave: a US-based propensity-matched cohort study Wan-Hsuan Hsu, Bo-Wen Shiau, Po-Yu Huang, Ya-Wen Tsai, Jheng-Yan Wu, Ting-Hui Liu, et al. (+4)
5 [GO] 2025―Apr―24 Changes in the incidence, viral coinfection pattern and outcomes of pneumococcal hospitalizations during and after the COVID-19 pandemic King-Pui Florence Chan, Ting-Fung Ma, Hanshu Fang, Wai-Kai Tsui, James Chung-Man Ho, Mary Sau-Man Ip, Pak-Leung Ho
6 [GO] 2025―Feb―05 Outcomes of COVID-19 in the Omicron-predominant wave: large-scale real-world data analysis with a comparison to influenza Koichi Miyashita, Hironao Hozumi, Kazuki Furuhashi, Eiji Nakatani, Yusuke Inoue, Hideki Yasui, et al. (+7)
7 [GO] 2024―Nov―25 Oxygenation indices and early prediction of outcome in hypoxemic patients with COVID-19 pneumonia requiring noninvasive respiratory support in pulmonary intermediate care unit Raffaele Scala, Teresa Renda, Sonia Bambina, Luca Guidelli, Stefania Arniani, Laura Carrassa, Simon Oczkowski
8 [GO] 2024―Okt―25 Effect of the Covid-19 pandemic on hospitalizations for non-Covid-19-pneumonia and exacerbations of chronic obstructive pulmonary diseases in Switzerland: comparison of national data between 2020/2021 and 2015-2019 Carla Bürke, Florent Baty, Frank Rassouli, Martin H. Brutsche, Werner C. Albrich
9 [GO] 2024―Okt―25 Clinical implications of persistently increased blood urea nitrogen/serum creatinine ratio (PI-BUN/Cr) in severe COVID-19 patients Gustavo Casas Aparicio, Rosario Fernández Plata, Anjarath Higuera Iglesias, David Martínez Briseño, Rolando Claure-Del Granado, Manuel Castillejos Lopez, et al. (+16)
10 [GO] 2024―Sep―05 Etiology and antimicrobial susceptibility patterns of bacteria causing pneumonia among adult patients with signs and symptoms of lower respiratory tract infections during the COVID-19 pandemic in Mwanza, Tanzania: a cross-sectional study Johannes Rukyaa, Martha F. Mushi, Vitus Silago, Prisca Damiano, Katherine Keenan, Wilber Sabiiti, et al. (+3)
11 [GO] 2024―Jun―25 Obtaining patient phenotypes in SARS-CoV-2 pneumonia, and their association with clinical severity and mortality Fernando García-García, Dae-Jin Lee, Mónica Nieves-Ermecheo, Olaia Bronte, Pedro Pablo España, José María Quintana, et al. (+4)
12 [GO] 2024―Jun―05 Back to the future: the novel art of digital auscultation applied in a prospective observational study of critically ill Covid-19 patients Evangelos Kaimakamis, Serafeim Kotoulas, Myrto Tzimou, Christos Karachristos, Chrysavgi Giannaki, Vassileios Kilintzis, et al. (+8)
13 [GO] 2024―Feb―25 Safety and efficacy of favipiravir in COVID-19 patients with pneumonia. A randomized, double-blind, placebo-controlled study (FAVID) Juan P. Horcajada, Rebeca Aldonza, Mónica Real, Silvia Castañeda-Espinosa, Elena Sendra, Joan Gomez-Junyent, et al. (+22)
14 [GO] 2024―Jan―05 Serum soluble toll-like receptor 4 and risk for clinical severity in COVID-19 patients Maha E. Houssen, Marwa O. Elmaria, Dina Badr, Rasha El-Mahdy, Mayada A. Ghannam, Shaimaa El-Ashwah, et al. (+2)
15 [GO] 2023―Nov―05 Time to recovery and its determinant factors among patients with COVID-19 in Assosa COVID-19 treatment center, Western Ethiopia Maru Zewdu Kassie, Molalign Gualu Gobena, Yihenew Mitiku Alemu, Awoke Seyoum Tegegne
16 [GO] 2023―Okt―05 Risk of subsequent lower respiratory tract infection (LRTI) after hospitalization for COVID-19 LRTI and non-COVID-19 LRTI: a retrospective cohort study Katia J. Bruxvoort, Heidi Fischer, Joseph A. Lewnard, Vennis X. Hong, Magdalena Pomichowski, Lindsay R. Grant, et al. (+3)
17 [GO] 2023―Sep―25 Thymalfasin therapy accelerates COVID-19 pneumonia rehabilitation through anti-inflammatory mechanisms Zirui Wang, Cong Wang, Xiaohua Fei, Haixing Wu, Peiqin Niu, Changxing Shen
18 [GO] 2023―Mai―25 Effects of pneumococcal conjugate vaccines on reducing the risk of respiratory disease associated with coronavirus infection Eileen M. Dunne, Marta C. Nunes, Mary P. E. Slack, Christian Theilacker, Bradford D. Gessner
19 [GO] 2022―Nov―25 Comparing the demographics and laboratory biomarkers of the COVID-19 Omicron wave and the Alpha wave in a predominantly Afro-Caribbean patient population in New York City Hye Won Shin, Alecia James, Theresa Feng, Lillian Chow, Robert Foronjy
20 [GO] 2021―Dez―06 Acute respiratory distress syndrome in COVID-19: possible mechanisms and therapeutic management Anolin Aslan, Cynthia Aslan, Naime Majidi Zolbanin, Reza Jafari
21 [GO] 2021―Apr―24 The role of co-infections and secondary infections in patients with COVID-19 Charles Feldman, Ronald Anderson
22 [GO] 2021―Jan―06 Legionnaires’ disease in the time of COVID-19 Kelsie Cassell, J Lucian Davis, Ruth Berkelman
 [1] 

22 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.003 sec